Bright Minds Biosciences DRUG
NASDAQ DRUG
$50.69 +1.48 (+3.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) Long-Term Investments (2020 - 2021)

Updated

Bright Minds Biosciences (DRUG) reported Long-Term Investments of -$26,723 for fiscal Q1 2022 (quarter ended Dec 31, 2021).

Analysis

Bright Minds Biosciences (DRUG) Long-Term Investments (2020 - 2021) Analysis & Trends

At the end of FY2021 (ended Sep 30, 2021), Bright Minds Biosciences posted Long-Term Investments of -$26,652.

  • By fiscal year, Long-Term Investments came in at $743.97 in FY2020.
  • The fiscal Q1 2022 figure ranks as the highest quarterly Long-Term Investments since fiscal Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 266.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.56 Bn
10 Bright Minds Biosciences 387.06 Mn 387.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -26,722.73
Sep 30, 2021 -26,758.88
Jun 30, 2021 -27,402.85
Sep 30, 2020 750.42
API Access

Bright Minds Biosciences Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=DRUG&period=max&api_key=YOUR_API_KEY